Qube Research & Technologies (QRT) Portfolio holdings
AUM
$72B
1-Year Return
7.86%
This Quarter Return
+1.53%
1 Year Return
+7.86%
3 Year Return
+23.62%
5 Year Return
+38.38%
10 Year Return
–
AUM
$17.5B
AUM Growth
+$858M
(+5.2%)
Cap. Flow
+$264M
Cap. Flow
% of AUM
1.51%
Top 10 Holdings %
Top 10 Hldgs %
8.09%
Holding
3,138
New
794
Increased
765
Reduced
787
Closed
711
Top Buys
| 1 |
Cigna
CI
|
+$161M |
| 2 |
Honeywell
HON
|
+$149M |
| 3 |
ConocoPhillips
COP
|
+$136M |
| 4 |
Abbott
ABT
|
+$115M |
| 5 |
Danaher
DHR
|
+$112M |
Top Sells
| 1 |
Apple
AAPL
|
+$201M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$123M |
| 3 |
Texas Instruments
TXN
|
+$117M |
| 4 |
CME Group
CME
|
+$115M |
| 5 |
Palo Alto Networks
PANW
|
+$112M |
Sector Composition
| 1 | Technology | 17.85% |
| 2 | Consumer Discretionary | 14.96% |
| 3 | Healthcare | 14.56% |
| 4 | Financials | 14.37% |
| 5 | Industrials | 12.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Hormel Foods
HRL
$13.8B
| $1.75M | 0.01% |
43,793
-124,698
| -74% | -$4.97M |
|
1002
MaxLinear
MXL
$1.37B
| $1.74M | 0.01% |
49,472
-17,292
| -26% | -$609K |
|
1003
BGC Group
BGC
$4.82B
| $1.74M | 0.01% |
332,291
+231,447
| +230% | +$1.21M |
|
|
ITCI
1004
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.74M | 0.01% |
+32,069
| New | +$1.74M |
|
1005
MGP Ingredients
MGPI
$596M
| $1.74M | 0.01% |
17,939
-1,666
| -8% | -$161K |
|
1006
Clean Harbors
CLH
$12.7B
| $1.73M | 0.01% |
12,148
-77,320
| -86% | -$11M |
|
1007
Fabrinet
FN
$12.8B
| $1.73M | 0.01% |
+14,581
| New | +$1.73M |
|
1008
Steelcase
SCS
$1.93B
| $1.73M | 0.01% |
205,577
-103,764
| -34% | -$874K |
|
1009
CGI
GIB
$20.8B
| $1.72M | 0.01% |
+17,908
| New | +$1.72M |
|
1010
Global Net Lease
GNL
$1.81B
| $1.72M | 0.01% |
133,626
+103,157
| +339% | +$1.33M |
|
1011
Pacific Biosciences
PACB
$351M
| $1.71M | 0.01% |
147,941
-531,332
| -78% | -$6.15M |
|
1012
iShares MSCI Emerging Markets ex China ETF
EMXC
$13.1B
| $1.71M | 0.01% |
34,721
-2,719
| -7% | -$134K |
|
|
RVNC
1013
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.71M | 0.01% |
53,021
-88,859
| -63% | -$2.86M |
|
1014
Fresh Del Monte Produce
FDP
$1.71B
| $1.71M | 0.01% |
56,688
+3,641
| +7% | +$110K |
|
|
AGEN
1015
Agenus
AGEN
$143M
| $1.71M | 0.01% |
57,206
+49,054
| +602% | +$1.46M |
|
1016
Ambac
AMBC
$413M
| $1.71M | 0.01% |
+110,177
| New | +$1.71M |
|
1017
Terreno Realty
TRNO
$6.05B
| $1.7M | 0.01% |
26,345
+3,247
| +14% | +$210K |
|
1018
Rocket Pharmaceuticals
RCKT
$341M
| $1.69M | 0.01% |
+98,649
| New | +$1.69M |
|
1019
Supernus Pharmaceuticals
SUPN
$2.55B
| $1.68M | 0.01% |
46,326
+14,151
| +44% | +$513K |
|
|
SBR
1020
Sabine Royalty Trust
SBR
$1.12B
| $1.68M | 0.01% |
+23,363
| New | +$1.68M |
|
1021
DXC Technology
DXC
$2.51B
| $1.68M | 0.01% |
65,591
-353,284
| -84% | -$9.03M |
|
1022
Archer Daniels Midland
ADM
$29.6B
| $1.68M | 0.01% |
21,032
+13,655
| +185% | +$1.09M |
|
1023
LKQ Corp
LKQ
$8.31B
| $1.67M | 0.01% |
29,460
-60,274
| -67% | -$3.42M |
|
1024
COPT Defense Properties
CDP
$3.46B
| $1.67M | 0.01% |
+70,481
| New | +$1.67M |
|
1025
Eagle Bancorp
EGBN
$615M
| $1.67M | 0.01% |
49,889
+37,958
| +318% | +$1.27M |
|